Clinical Trial Update: A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bioequivalence and food effect of TAK-438ASA tablet in healthy volunteers has been completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• TAK-438ASA Tablet (TAK-438ASA)

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2019-11-04